 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment Tisento Developing Zagociguat in MELAS*, a Rare Primary Mitochondrial Disease with No Approved Therapies, Leveraging Extensive Preclinical and Clinical Data Generated by Cyclerion CAMBRIDGE, Mass...

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN  Free Report)s stock price traded up 0.7% during mid-day trading on Tuesday . The stock traded as high as $4.17 and last traded at $4.15. 6,061 shares were traded during mid-day trading, a decline of 60% from the average session volume of 15,...

Cyclerion Therapeutics (NASDAQ:CYCN) Trading 0.7% Higher

Cyclerion Therapeutics (NASDAQ:CYCN Get Rating) and ORIC Pharmaceuticals (NASDAQ:ORIC Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, ...

Head to Head Contrast: Cyclerion Therapeutics (NASDAQ:CYCN) versus ORIC Pharmaceuticals (NASDAQ:ORIC)

CAMBRIDGE, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Cyclerion or the Company) (Nasdaq: CYCN) today announced that it has received a formal notice from The Nasdaq Stock Market (Nasdaq) stating that Cyclerion has regained compliance with the $1.00 per share minimum bid ...

Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement

ORIC Pharmaceuticals (NASDAQ:ORIC  Get Rating) and Cyclerion Therapeutics (NASDAQ:CYCN  Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst ...

Comparing Cyclerion Therapeutics (NASDAQ:CYCN) and ORIC Pharmaceuticals (NASDAQ:ORIC)

For the last three days, A.I.dvisor has detected that CYCN's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for CYCN, and traders may view it as a Sell signal for the next month. Traders may consider ...

Cyclerion Therapeutics (CYCN, $5.26) Aroon Indicator entered a Downtrend on May 19, 2023.

This indicator may be signaling that CYCN's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Cyclerion Therapeutics (CYCN, $5.26) entered Downtrend as Momentum indicator drops below 0 level on May 19, 2023

Cyclerion Therapeutics (CYCN, $6.16) Aroon Indicator entered a Downtrend on May 18, 2023.

This indicator may be signaling CYCN's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Cyclerion Therapeutics (CYCN, $6.16) entered Uptrend as Momentum indicator ascends above 0 level on May 18, 2023

Cyclerion Therapeutics (CYCN, $5.03) Aroon Indicator entered a Downtrend on May 17, 2023.

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Watchers	4,312
52-Wk Low	$2.77
52-Wk High	$19.80

Market Cap	$9.12M
Volume (M)	3,408.00
52-Wk High	$19.80
52-Wk Low	$2.77

CYCN Cyclerion Therapeutics Inc

About

Feed

News

Sentiment

Fundamentals